

AOD-9604
$59.99 $39.99
AOD-9604 (GH Fragment 176–191) Product Information 🔬
This is a specialized research product of AOD-9604, a synthetic peptide fragment of growth hormone, strictly intended For In Vitro Research Use Only — Not for Human or Veterinary Use.
Description & Application
Description: AOD-9604 is a synthetic peptide fragment corresponding to amino acids 176–191 of human growth hormone.1
Targeted Activity: It is studied in vitro for its potential role in regulating fat metabolism.2 AOD-9604 is believed to stimulate lipolysis (breakdown of stored fat) and inhibit lipogenesis (blocking formation of new fat cells) without exhibiting the broader growth-promoting activity associated with full-length growth hormone.3
Research Focus: Due to this targeted activity, AOD-9604 is commonly researched in models investigating:
Obesity and metabolic disorders.
Energy metabolism and fat regulation.
GH fragment signaling pathways.
Specifications & Storage
Unit Size: 5mg (lyophilized powder, single vial).
Form: Crystalline lyophilized peptide.
Sequence: $\text{Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Gly-Ser-Cys-Gly-Phe}$.
Molecular Formula: $\text{C}_{72}\text{H}_{111}\text{N}_{19}\text{O}_{20}\text{S}_{2}$.
Molecular Weight: $\sim 1815.08 \text{ Da}$.
Storage (Dry): Store dry at $2^{\circ}\text{C}–8^{\circ}\text{C}$ in a sealed container.
⚠️ Legal & Intended Use
Intended Use: This compound is intended strictly for in vitro laboratory research purposes only. It is not approved for human or animal use and must not be incorporated into food, drugs, cosmetics, or dietary supplements.
Legal Disclaimer: This product has not been evaluated by the U.S. Food and Drug Administration (FDA). No claims are made regarding diagnosis, treatment, cure, or prevention of disease. Use is restricted to qualified professionals in certified laboratory environments.
Terms of Sale: The buyer confirms they are a qualified researcher or institution, fully responsible for lawful handling, storage, and research use of this compound. All sales are final.
Contact
Get in touch with our team today.
Connect
© 2025. All rights reserved.
